Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Eye prosthesis – Intraocular lens
Patent
1995-05-09
1996-08-27
Jones, Mary Beth
Prosthesis (i.e., artificial body members), parts thereof, or ai
Eye prosthesis
Intraocular lens
A61F 216
Patent
active
055496709
ABSTRACT:
An IOL implantable in an eye including an optic having an optical portion for directing light toward the retina of the eye and a cell barrier portion for inhibiting cell growth from the eye in front of or in back of the optical portion. The cell barrier portion circumscribes the optical portion, is incapable of focusing light on the retina and includes an irregularly configured structure, for example, irregular grooves. At least one elongated fixation member is coupled to the optic for use in fixing the optic in the eye.
REFERENCES:
patent: 2043840 (1936-06-01), Singer
patent: 3034403 (1962-05-01), Neefe
patent: 3454332 (1969-07-01), Siegel
patent: 4435856 (1984-03-01), L'Esperance
patent: 4449257 (1984-05-01), Koeniger
patent: 4451938 (1984-06-01), Kelman
patent: 4601722 (1986-07-01), Kelman
patent: 4605409 (1986-08-01), Kelman
patent: 4676791 (1987-06-01), LeMaster et al.
patent: 4702244 (1987-10-01), Mazzocco
patent: 4743254 (1988-05-01), Davenport
patent: 4808181 (1989-02-01), Kelman
patent: 5002571 (1991-03-01), O'Donnell, Jr. et al.
patent: 5011494 (1991-04-01), von Recum et al.
patent: 5076684 (1991-12-01), Simpson et al.
patent: 5089023 (1992-02-01), Swanson
patent: 5370687 (1994-12-01), Poler
patent: 5405385 (1995-04-01), Heimke et al.
Effect of posterior chamber intraocular lens design and surgical placement on postoperative outcome, Martin et al. Cataract Refract Surg., vol. 18, Jul. 1992.
Spreading and Orientation of Epithelial Cells on Grooved Substrata, Brunette, Experimental Cell Research 167 (1986) 203-217.
The Rayner Choyce Mark VIII Anterior Chamber Implant, Catalogue No. 469.
Cunanan Crystal M.
Sussman Glenn R.
Young Craig
Allergan Inc.
Jones Mary Beth
Uxa Frank J.
LandOfFree
IOL for reducing secondary opacification does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IOL for reducing secondary opacification, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IOL for reducing secondary opacification will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1053280